Starling Oncology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $203.4M
Liabilities Breakdown FY2021
Total Liabilities: $99.3M
Asset Breakdown
Total Assets: $203.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $115.2M | 56.6% |
| Accounts Receivable | $20.0M | 9.8% |
| Inventory | $6.4M | 3.2% |
| Property, Plant & Equipment | $4.2M | 2.1% |
| Goodwill | $26.6M | 13.1% |
| Intangible Assets | $18.2M | 9.0% |
| Other Assets | $12.8M | 6.3% |
Liabilities Breakdown
Total Liabilities: $99.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $15.6M | 15.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $83.7M | 84.3% |